InsightfulValue
← Home

Sysmex
Sysmex

Healthcare & biotech / Medical equipment and devices


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (4)
Sysmex

πŸ“Š Get full analytics about Sysmex

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

Price
Live  
Overview
Sysmex Corporation is a Japanese company that develops and manufactures medical diagnostic equipment and software for hospitals, clinics, and medical research organizations worldwide. The company was founded in 1968 and is headquartered in Kobe, Japan.
Sysmex specializes in the field of in vitro diagnostics (IVD) and is a leading provider of hematology, urinalysis, and flow cytometry systems. The company also offers solutions for coagulation testing, molecular diagnostics, and lab automation. Their products are used for the diagnosis and monitoring of diseases such as anemia, leukemia, urinary tract infections, and cancer.
In addition to their medical devices, Sysmex also offers software solutions and services for data management, quality control, and laboratory management. Their products are designed to improve efficiency, accuracy, and reliability in healthcare settings.
Sysmex has a global presence with subsidiaries and sales and service offices in over 35 countries. They work closely with healthcare professionals and researchers to develop innovative solutions that meet the evolving needs of the healthcare industry.
The company's corporate mission is to "shape the advancement of healthcare" by providing high-quality diagnostic products and services that contribute to the early detection, prevention, and treatment of diseases. Sysmex is committed to improving patient outcomes and promoting the overall advancement of healthcare worldwide.
How to explain to a 10 year old kid about the company?
Sysmex is a company that helps doctors and hospitals take care of people when they are sick. They do this by making special machines and tools that can test people’s blood and other samples to find out what might be wrong with them. Think of it like a superhero that helps doctors figure out if someone has an illness or if they are healthy!
Now, how does Sysmex make money? When hospitals and doctors buy their machines and tools, they pay money for them. They also sell special parts and provide support and services to help hospitals use their machines well. So, every time a hospital gets a new testing machine or needs help with the ones they have, Sysmex earns money.
Sysmex is successful for a few reasons. First, their machines are very accurate and help doctors get fast answers, which is really important when someone is sick. Second, they are always looking for new ways to improve their machines and make them even better. Lastly, there are lots of hospitals and clinics all around the world that need these kinds of tests, so there is a big market for what Sysmex does.
In the future, Sysmex will likely continue to do well because people will always need medical testing, especially as science and technology keep improving. They are good at what they do and are always trying to be even better, which means they will likely stay a big player in the healthcare world.

What is special about the company?
Sysmex

πŸ“ˆ Want to read more about Sysmex?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

MS4gQ3V0dG luZy1lZGdl IHRlY2hub2 xvZ3k6IFN5 c21leCBpcy BhIGdsb2Jh bCBsZWFkZX IgaW4gbWVk aWNhbCBkaW Fnbm9zdGlj IGVxdWlwbW VudCBhbmQg c29sdXRpb2 5zLiBUaGV5 IGNvbnRpbn VvdXNseSBp bnZlc3QgaW 4gcmVzZWFy Y2ggYW5kIG RldmVsb3Bt ZW50IHRvIG RldmVsb3Ag Y3V0dGluZy 1lZGdlIHRl Y2hub2xvZ3 kgYW5kIGlu bm92YXRpdm UgcHJvZHVj dHMuPGJyPj IuIEdsb2Jh bCBwcmVzZW 5jZTogU3lz bWV4IGhhcy BhIHN0cm9u ZyBnbG9iYW wgcHJlc2Vu Y2UsIHdpdG ggYSBzYWxl cyBhbmQgc2 VydmljZSBu ZXR3b3JrIG luIG1vcmUg dGhhbiAxOT AgY291bnRy aWVzLiBUaG lzIGFsbG93 cyB0aGVtIH RvIHByb3Zp ZGUgc3VwcG 9ydCBhbmQg c29sdXRpb2 5zIHRvIGhl YWx0aGNhcm UgZmFjaWxp dGllcyBhcm 91bmQgdGhl IHdvcmxkLj xicj4zLiBG b2N1cyBvbi BoZWFsdGhj YXJlOiBTeX NtZXggaXMg ZGVkaWNhdG VkIHRvIGlt cHJvdmluZy BoZWFsdGhj YXJlIG91dG NvbWVzIGFu ZCBwYXRpZW 50IHdlbGwt YmVpbmcuIF RoZWlyIHBy b2R1Y3RzIG FuZCBzZXJ2 aWNlcyBhcm UgZGVzaWdu ZWQgdG8gYX NzaXN0IGlu IHRoZSBkaW Fnbm9zaXMs IHRyZWF0bW VudCwgYW5k IG1vbml0b3 Jpbmcgb2Yg ZGlzZWFzZX MgYW5kIGNv bmRpdGlvbn MuPGJyPjQu IEF1dG9tYX Rpb24gYW5k IGVmZmljaW VuY3k6IE9u ZSBvZiB0aG Uga2V5IGhp Z2hsaWdodH Mgb2YgU3lz bWV4IHByb2 R1Y3RzIGlz IHRoZWlyIG F1dG9tYXRp b24gYW5kIG VmZmljaWVu Y3kuIFRoZX kgaGF2ZSBk ZXZlbG9wZW QgYWR2YW5j ZWQgYXV0b2 1hdGlvbiBz eXN0ZW1zIH RoYXQgY2Fu IGhhbmRsZS BoaWdoIHZv bHVtZXMgb2 YgZGlhZ25v c3RpYyB0ZX N0cyBxdWlj a2x5IGFuZC BhY2N1cmF0 ZWx5Ljxicj 41LiBDb21t aXRtZW50IH RvIHF1YWxp dHk6IFN5c2 1leCBpcyBj b21taXR0ZW QgdG8gbWFp bnRhaW5pbm cgdGhlIGhp Z2hlc3Qgc3 RhbmRhcmRz IG9mIHF1YW xpdHkgaW4g dGhlaXIgcH JvZHVjdHMg YW5kIHNlcn ZpY2VzLiBU aGV5IGhhdm UgY2VydGlm aWNhdGlvbn MgYW5kIGFj Y3JlZGl0YX Rpb25zIGZy b20gaW50ZX JuYXRpb25h bCBvcmdhbm l6YXRpb25z LCBlbnN1cm luZyB0aGF0 IHRoZWlyIH Byb2R1Y3Rz IG1lZXQgc3 RyaWN0IHF1 YWxpdHkgYW 5kIHNhZmV0 eSBzdGFuZG FyZHMuPGJy PjYuIFN0cm 9uZyBwYXJ0 bmVyc2hpcH M6IFN5c21l eCBoYXMgc3 Ryb25nIHBh cnRuZXJzaG lwcyB3aXRo IGhlYWx0aG NhcmUgb3Jn YW5pemF0aW 9ucywgcmVz ZWFyY2ggYW 5kIGFjYWRl bWljIGluc3 RpdHV0aW9u cywgYW5kIG 90aGVyIGlu ZHVzdHJ5IG xlYWRlcnMu IFRoZXNlIG NvbGxhYm9y YXRpb25zIG hlbHAgZHJp dmUgaW5ub3 ZhdGlvbiBh bmQgaW1wcm 92ZSBkaWFn bm9zdGljIG NhcGFiaWxp dGllcy48Yn I+Ny4gRW52 aXJvbm1lbn RhbCBzdXN0 YWluYWJpbG l0eTogU3lz bWV4IGlzIG NvbW1pdHRl ZCB0byByZW R1Y2luZyBp dHMgZW52aX Jvbm1lbnRh bCBpbXBhY3 QgYW5kIHBy b21vdGluZy BzdXN0YWlu YWJpbGl0eS 4gVGhleSBo YXZlIGltcG xlbWVudGVk IHNldmVyYW wgZWNvLWZy aWVuZGx5IG luaXRpYXRp dmVzLCBzdW NoIGFzIGRl dmVsb3Bpbm cgZW5lcmd5 LWVmZmljaW VudCBwcm9k dWN0cyBhbm QgcmVkdWNp bmcgd2FzdG UuPGJyPjgu IENvcnBvcm F0ZSBzb2Np YWwgcmVzcG 9uc2liaWxp dHk6IFN5c2 1leCBoYXMg YSBzdHJvbm cgc2Vuc2Ug b2YgY29ycG 9yYXRlIHNv Y2lhbCByZX Nwb25zaWJp bGl0eSwgd2 l0aCBhIGZv Y3VzIG9uIH Byb21vdGlu ZyBoZWFsdG ggYW5kIHdl bGwtYmVpbm csIHN1cHBv cnRpbmcgY2 9tbXVuaXRp ZXMsIGFuZC BzdXN0YWlu YWJsZSBidX NpbmVzcyBw cmFjdGljZX MuPGJyPjku IENvbnRpbn VvdXMgaW1w cm92ZW1lbn Q6IFN5c21l eCBwbGFjZX MgYSBzdHJv bmcgZW1waG FzaXMgb24g Y29udGludW 91cyBpbXBy b3ZlbWVudC BhbmQgc3Rh eWluZyBhaG VhZCBvZiB0 ZWNobm9sb2 dpY2FsIGFk dmFuY2VtZW 50cy4gVGhl eSBoYXZlIG EgY3VsdHVy ZSBvZiBpbm 5vdmF0aW9u IGFuZCBhcm UgY29uc3Rh bnRseSBzZW VraW5nIHdh eXMgdG8gaW 1wcm92ZSB0 aGVpciBwcm 9kdWN0cyBh bmQgc2Vydm ljZXMuPGJy PjEwLiBTdH JvbmcgZmlu YW5jaWFsIH BlcmZvcm1h bmNlOiBTeX NtZXggaGFz IGEgbG9uZy BoaXN0b3J5 IG9mIHN0cm 9uZyBmaW5h bmNpYWwgcG VyZm9ybWFu Y2UsIHdpdG ggY29uc2lz dGVudCByZX ZlbnVlIGdy b3d0aCBhbm QgcHJvZml0 YWJpbGl0eS 4gVGhpcyBp bmRpY2F0ZX MgdGhlIGNv bXBhbnkncy BzdGFiaWxp dHkgYW5kIG NhcGFiaWxp dHkgdG8gZG VsaXZlciBo aWdoLXF1YW xpdHkgcHJv ZHVjdHMgYW 5kIHNlcnZp Y2VzLg==
What the company's business model?
Sysmex

πŸ“ˆ Want to read more about Sysmex?

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

VGhlIFN5c2 1leCBjb21w YW55J3MgYn VzaW5lc3Mg bW9kZWwgaX MgZm9jdXNl ZCBvbiB0aG UgZGV2ZWxv cG1lbnQsIG 1hbnVmYWN0 dXJpbmcsIG FuZCBzYWxl IG9mIHZhcm lvdXMgZGlh Z25vc3RpYy BhbmQgdGVz dGluZyBlcX VpcG1lbnQg Zm9yIG1lZG ljYWwgZmFj aWxpdGllcy BhbmQgbGFi b3JhdG9yaW VzLiBUaGUg Y29tcGFueS Bwcm9kdWNl cyBhIHdpZG UgcmFuZ2Ug b2YgcHJvZH VjdHMgcmVs YXRlZCB0by BoZW1hdG9s b2d5LCB1cm luYWx5c2lz LCBjb2FndW xhdGlvbiwg Y2VsbHVsYX IgYW5hbHlz aXMsIGFuZC BvdGhlciBm aWVsZHMgb2 YgY2xpbmlj YWwgbGFib3 JhdG9yeSB0 ZXN0aW5nLi BUaGVpciBi dXNpbmVzcy Btb2RlbCBh bHNvIGluY2 x1ZGVzIHBy b3ZpZGluZy Bzb2Z0d2Fy ZSBzb2x1dG lvbnMgYW5k IHN1cHBvcn Qgc2Vydmlj ZXMsIGFzIH dlbGwgYXMg Y29uZHVjdG luZyByZXNl YXJjaCBhbm QgZGV2ZWxv cG1lbnQgdG 8gY29udGlu dW91c2x5IG ltcHJvdmUg dGhlaXIgcH JvZHVjdHMu IEFkZGl0aW 9uYWxseSwg U3lzbWV4IG hhcyBlc3Rh Ymxpc2hlZC BwYXJ0bmVy c2hpcHMgYW 5kIGNvbGxh Ym9yYXRpb2 5zIHdpdGgg b3RoZXIgY2 9tcGFuaWVz IGFuZCBpbn N0aXR1dGlv bnMgdG8gZX hwYW5kIHRo ZWlyIHJlYW NoIGFuZCBv ZmZlciBidW 5kbGVkIHNv bHV0aW9ucy B0byBjdXN0 b21lcnMu
Is AI a threat?
AI can pose potential threats and opportunities to Sysmex’s products and services, primarily in the areas of substitution, disintermediation, and margin pressure.
1. Substitution: AI has the potential to enhance diagnostic tools and laboratory technologies that compete with traditional products offered by Sysmex. If AI-driven solutions demonstrate superior accuracy, speed, or cost-effectiveness in clinical diagnostics, they could replace Sysmex’s offerings, leading to reduced demand for their products.
2. Disintermediation: As AI technologies become more advanced, there is a possibility that healthcare providers may adopt direct-to-consumer testing or AI-based analysis tools that bypass traditional laboratory equipment and services. This could undermine Sysmex’s role in the diagnostic process, resulting in decreased reliance on their products.
3. Margin Pressure: The integration of AI in diagnostics can lead to increased competition, as new entrants with innovative, AI-driven solutions may offer lower-cost alternatives. This competitive landscape could pressure Sysmex to reduce prices or invest in R&D continuously to maintain its market position, potentially impacting profit margins.
However, it is also essential to consider that Sysmex could leverage AI to enhance its own products and services, streamlining operations, improving diagnostics accuracy, and creating new market opportunities. Ultimately, the impact of AI on Sysmex will depend on how effectively the company adapts to these technological advancements.
Sensitivity to interest rates
The sensitivity of Sysmex’s earnings, cash flow, and valuation to changes in interest rates can be assessed through several factors:
1. Financing Costs: If Sysmex relies on debt for financing, increases in interest rates could raise the cost of borrowing. This would affect net income due to higher interest expenses, thereby impacting overall earnings.
2. Discount Rates: Higher interest rates generally increase the discount rate used in valuation models, such as discounted cash flow (DCF) analysis. This could lead to a lower present value of future cash flows, negatively affecting the company’s valuation.
3. Investment Decisions: Sysmex’s capital expenditures and R&D investments could be influenced by interest rate changes. Higher rates may lead to more cautious capital spending, potentially affecting long-term growth and cash flow generation.
4. Market Demand: Changes in interest rates can influence economic conditions, affecting healthcare budgets and demand for Sysmex’s products. For instance, in tighter financial conditions, hospitals may reduce capital spending, impacting sales.
5. Cash Flow Management: If Sysmex has significant cash reserves, rising interest rates may benefit the company as they could earn higher returns on cash holdings. Conversely, if rates lead to an economic slowdown, cash flows might be negatively affected due to reduced sales.
Overall, the specific impact on Sysmex’s earnings, cash flow, and valuation would depend on the magnitude of interest rate changes, the company’s financial structure, and the broader economic context.
Interesting facts about the company
Sysmex

πŸ“ˆ Want to read more about Sysmex?

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvMG Y3UlJjRTVO dkMyWkRNdH VVNkIud2Vi cCIgYWx0PS JTeXNtZXgi IHRpdGxlPS JTeXNtZXgi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9OTAg d2lkdGg9OT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgU3lzbWV4 PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+GkyBE aXNjb3Zlci A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+IOKAlC BmcmVlIGVC b29rIQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L3A+CgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID EycHg7IGZv bnQtc2l6ZT ogMTNweDsg Y29sb3I6IC M0NDQ7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIFNp Z24gdXAgbm 93IGFuZCBn ZXQgb3VyIG ZyZWUgZUJv b2sgCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8Yj5UaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzPC 9iPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwhLS 0KICAgICAg ICAgICAgIC AgICAgICAg ICAgPGRpdi BzdHlsZT0n bWFyZ2luLX RvcDogMTZw eDsgZm9udC 1zaXplOiAx NHB4OyBjb2 xvcjogIzQ0 NDsgZm9udC 1mYW1pbHk6 IC1hcHBsZS 1zeXN0ZW0s IEJsaW5rTW FjU3lzdGVt Rm9udCwgU2 Vnb2UgVUks IFJvYm90by wgSGVsdmV0 aWNhIE5ldW UsIHNhbnMt c2VyaWY7IG xpbmUtaGVp Z2h0OiAxLj Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIEhhdmUg eW91IGhlYX JkIGFib3V0 IG91ciBzaG 9ydCA8c3Ry b25nIHN0eW xlPSdmb250 LXdlaWdodD ogNjAwOyc+ RGFpbHkgVm lkZW8gTmV3 c2xldHRlcj wvc3Ryb25n Pj8KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxhIGhyZW Y9J2h0dHBz Oi8vd3d3Lm luc2lnaHRm dWx2YWx1ZS 5jb20vbmV3 c2xldHRlci 5waHAnIHRh cmdldD0nX2 JsYW5rJyBz dHlsZT0nY2 9sb3I6ICMw MDdCRkY7IH RleHQtZGVj b3JhdGlvbj ogbm9uZTsg Zm9udC13ZW lnaHQ6IDUw MDsgbWFyZ2 luLWxlZnQ6 IDZweDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIEZpbmQg b3V0IG1vcm UKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAKICAgIC AgICAKICAg ICAgICA8c3 BhbiBjbGFz cz0nYmx1cn JlZC10ZXh0 Jz4KICAgIC AgICAgICAg TVM0Z1UzbH piVyBWNElF TnZjbkJ2IG NtRjBhVzl1 SUcgbHpJR0 VnU21GdyBZ VzVsYzJVZ1 kyIDl0Y0dG dWVTQjAgYU dGMElITnda VyBOcFlXeH BlbVZ6IElH bHVJSFJvWl MgQndjbTlr ZFdOMCBhVz l1SUdGdVpD IEJrYVhOMG NtbGkgZFhS cGIyNGdiMi BZZ2JXVmth V05oIGJDQm thV0ZuYm0g OXpkR2xqSU dWeCBkV2x3 YldWdWRDIE JoYm1RZ2FX NW0gYjNKdF lYUnBiMiA0 Z2MzbHpkR1 Z0IGN5NDhZ bkkrTWkgNG dWR2hsSUdO diBiWEJoYm 5rZ2QyIEZ6 SUdadmRXNW sgWldRZ2FX NGdTMiA5aV pTd2dTbUZ3 IFlXNGdhVz RnTVQgazJP Q0JpZVNCVS BiMmh5ZFNC WllXIDFoWj NWamFHa3Mg SUdFZ2NISn ZiVyBsdVpX NTBJR1Z1IF oybHVaV1Z5 SUcgRnVaQ0 JsYm5SeSBa WEJ5Wlc1bG RYIElnYVc0 Z2RHaGwgSU dacFpXeGtJ RyA5bUlHaG xiV0YwIGIy eHZaM2t1UE cgSnlQak11 SUZSbyBaU0 J1WVcxbElG IE41YzIxbG VDQnAgY3lC aElHTnZiVy BKcGJtRjBh Vzl1IElHOW 1JSFJvWlMg QjNiM0prY3 lCeiBlWE4w WlcwZ1lXID VrSUcxbFpH bGogWVd3Z1 pYaGhiVyBs dVlYUnBiMj RzIElHaHBa MmhzYVcgZG 9kR2x1WnlC MCBhR1VnWT I5dGNHIEZ1 ZWVLQW1YTW cgWm05amRY TWdiMiA0Z2 JXVmthV05o IGJDQmthV0 ZuYm0gOXpk R2xqY3k0OC BZbkkrTkM0 Z1UzIGx6Yl dWNDRvQ1og Y3lCbWJHRm 5jMiBocGND QndjbTlrIG RXTjBJR2x6 SUcgbDBjeU JoZFhSdiBi V0YwWldRZ2 FHIFZ0WVhS dmJHOW4gZV NCaGJtRnNl WCBwbGNuTX NJSGRvIGFX Tm9JR0Z5Wl MgQjFjMlZr SUhSdiBJSE JsY21admNt IDBnWW14dm IyUWcgWTJW c2JDQmpiMy BWdWRITWdZ VzVrIElHOT BhR1Z5SUcg SnNiMjlrSU hSbCBjM1J6 TGp4aWNqID QxTGlCVWFH VWcgWTI5dG NHRnVlUyBC b1lYTWdZU0 J6IGRISnZi bWNnWjIgeH ZZbUZzSUhC eSBaWE5sYm 1ObExDIEIz YVhSb0lHOW 0gWm1salpY TWdZVyA1a0 lHMWhiblZt IFlXTjBkWE pwYm0gY2da bUZqYVd4cC BkR2xsY3lC cGJpIEJ2ZG 1WeUlERTUg TUNCamIzVn VkSCBKcFpY TWdZVzVrIE lISmxaMmx2 Ym4gTWdZWE p2ZFc1ayBJ SFJvWlNCM2 IzIEpzWkM0 OFluSSsgTm k0Z1UzbHpi VyBWNElHaG hjeUJoIElI TjBjbTl1Wn kgQmpiMjF0 YVhSdCBaVz UwSUhSdklI IE4xYzNSaG FXNWggWW1s c2FYUjVJRy BGdVpDQmpi M0p3IGIzSm hkR1VnYzIg OWphV0ZzSU hKbCBjM0J2 Ym5OcFltIG xzYVhSNUxD QjMgYVhSb0 lHbHVhWCBS cFlYUnBkbV Z6IElHWnZZ M1Z6WlcgUW diMjRnY21W ayBkV05wYm 1jZ1pXIDUy YVhKdmJtMW wgYm5SaGJD QnBiWCBCaF kzUXNJSEJ5 IGIyMXZkR2 x1WnkgQmth WFpsY25OcC BkSGtnWVc1 a0lHIGx1WT J4MWMybHYg Yml3Z1lXNW tJRyBkcGRt bHVaeUJpIF lXTnJJSFJ2 SUcgTnZiVz ExYm1sMCBh V1Z6TGp4aW NqIDQzTGlC SmJpQmggWk dScGRHbHZi aSBCMGJ5Qn BkSE1nIFky OXlaU0JpZF ggTnBibVZ6 Y3lCdiBaaU J0WldScFky IEZzSUdScF lXZHUgYjNO MGFXTnpMQy BCVGVYTnRa WGdnIGFHRn pJR1Y0Y0cg RnVaR1ZrSU dsdSBkRzhn YjNSb1pYIE lnYUdWaGJI Um8gWTJGeV pTQmhjbSBW aGN5d2dhVz VqIGJIVmth VzVuSUcgTm hibU5sY2lC ayBhV0ZuYm 05emRHIGxq Y3l3Z1pteH YgZHlCamVY UnZiVyBWMG Nua3NJR0Z1 IFpDQnNZV0 p2Y20gRjBi M0o1SUdsdS BabTl5YldG MGFXIE56TG p4aWNqNDQg TGlCVWFHVW dZMiA5dGNH RnVlU0JvIF lYTWdjbVZq WlcgbDJaV1 FnYm5WdCBa WEp2ZFhNZ1 lYIGRoY21S eklHRnUgWk NCeVpXTnZa MiA1cGRHbH Zibk1nIFpt OXlJR2wwY3 kgQnBibTV2 ZG1GMCBhWF psSUhCeWIy IFIxWTNSek lHRnUgWkNC amIyNTBjbS BsaWRYUnBi MjV6IElIUn ZJSFJvWlMg QnRaV1JwWT JGcyBJR2x1 WkhWemRIIE o1TENCcGJt TnMgZFdScG JtY2dZbSBW cGJtY2diR2 x6IGRHVmtJ Rzl1SUUgWn ZjbUpsYytL QSBtU0JCYz JsaDRvIENa Y3lBeU1EQW cgUW1WemRD QlZibSBSbG NpQkJJRUpw IGJHeHBiMj RnYkcgbHpk QzQ4WW5JKy BPUzRnVTNs emJXIFY0SU dseklHRnMg YzI4Z2FHVm hkbSBsc2VT QnBiblp2IG JIWmxaQ0Jw YmkgQnlaWE 5sWVhKaiBh Q0JoYm1RZ1 pHIFYyWld4 dmNHMWwgYm 5Rc0lIZHBk RyBnZ2IzWm xjaUF5IExE QXdNQ0JsYl ggQnNiM2xs WlhNZyBkMj l5YTJsdVp5 IEJwYmlCU0 prUWcgZEc4 Z1puVnlkRy BobGNpQmha SFpoIGJtTm xJRzFsWkcg bGpZV3dnZE dWaiBhRzV2 Ykc5bmVTID Q4WW5JK01U QXUgSUZSb1 pTQmpiMiAx d1lXNTU0b0 NaIGN5QnRh WE56YVcgOX VJR2x6SUhS diBJSE5vWV hCbElIIFJv WlNCaFpIWm ggYm1ObGJX VnVkQyBCdl ppQm9aV0Zz IGRHaGpZWE psSUcgSjVJ R055WldGMC BhVzVuSUha aGJIIFZsSU dadmNpQjAg YUdVZ2JXVm thVyBOaGJD QmhibVFnIG MyTnBaVzUw YVcgWnBZeU JqYjIxdCBk VzVwZEdsbG N5IEIzYVhS b0lHRWcgWW 1WemRDMXBi aSAxamJHRn pjeUJ3IGIz SjBabTlzYV cgOGdiMlln YVc1dSBiM1 poZEdsMlpT IEJrYVdGbm JtOXogZEds aklITnZiSC BWMGFXOXVj eTQ9CiAgIC AgICAgPC9z cGFuPgogIC AgICAgIAog ICAgICAgIA ==
See Company Q&A
Sysmex

πŸ“Š Get full analytics about Sysmex

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal